Atossa Therapeutics (ATOS) announced that the U.S. FDA issued a “Study May Proceed” letter for the company’s study in metastatic breast cancer ...
Researchers have identified serine threonine kinase 10 as a key regulator of platelet function, haemostasis and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback